BHARAT PARENTERALS LTD. Share Price

BHARAT PARENTERALS LTD. Share Price

NSE: BPLPHARMA
|
Pharmaceuticals
|
S Cap
₹ 1,518.20
+₹10.80 (0.72%)
1D
Last updated 02 Sep, 2026, 15:54 IST

BHARAT PARENTERALS LTD. Share Price Today

As of 3 Sep 2026, BHARAT PARENTERALS LTD. share price is ₹1,518.20. The stock opened at ₹1,513.00, compared to its previous close of ₹1,507.40. During today's trading session, BHARAT PARENTERALS LTD. share price moved in the range of ₹1,490.00 to ₹1,532.90, with an average price of ₹1,511.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,125.70 and a high of ₹1,649.00.


₹1,490.00
0.72% up today
₹1,532.90
1D LOW
1D HIGH

BHARAT PARENTERALS LTD. Returns Calculator


Circuit
L
H
₹1,214.60
₹1,821.80
52-week
L
H
₹1,125.70
₹1,649.00

About BHARAT PARENTERALS LTD.

BHARAT PARENTERALS LTD. Share Price
ISIN
INE365Y01019
Sector Market Cap
₹ 1,049.27 Cr

Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations. The Company offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies. It has a manufacturing facility spread over 30,000 square feet (sq. ft.) area with a large batch-sized capacity for general: tablets, capsules, oral liquids, eye drops, ointments, lotions, creams, and others.

BHARAT PARENTERALS LTD. Financial Highlights

  • Revenue: BHARAT PARENTERALS LTD. reported revenue of ₹354.97 crore in FY26 vs ₹352.00 crore in FY25. It showed an increase of 0.84% on a yearly basis.
  • Operating Profit: BHARAT PARENTERALS LTD. reported an operating loss of ₹21.42 crore in FY26 vs ₹33.95 crore in FY25. It showed an increase of 36.91% on a year-on-year basis.
  • Net Profit: BHARAT PARENTERALS LTD. reported a net loss of ₹27.31 crore in FY26 vs ₹43.68 crore in FY25. It showed an increase of 37.48% on a yearly basis.

BHARAT PARENTERALS LTD. Quarterly Result Highlights

  • BHARAT PARENTERALS LTD. reported revenue of ₹94.85 crore in Jun 2026, compared with ₹103.25 crore in Mar 2026, representing a decrease of 8.14% on a quarter-on-quarter (QoQ) basis.
  • BHARAT PARENTERALS LTD. reported an operating loss of ₹1.49 crore in Jun 2026, compared with ₹8.37 crore in Mar 2026, representing an increase of 82.20% on a quarter-on-quarter (QoQ) basis.
  • BHARAT PARENTERALS LTD. reported a loss of ₹3.56 crore in Jun 2026, compared with ₹8.16 crore in Mar 2026, reflecting an increase of 56.37% on a QoQ basis.
  • The earnings per share (EPS) of BHARAT PARENTERALS LTD. stood at ₹66.64 during Jun 2026.
Know more
Promoters
67.20%
FII
0.11%
Other DII
1.37%
Retail and other
31.31%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.11%
Dec 20250.11%
Mar 20260.11%
Jun 20260.11%
Mkt Cap Cr
1,049.27

P/E
-35.64

P/B
3.32

ROE
-2.54%

D/E
0.05

ROCE
-1.83%

Div. Yield
0.07%

EPS(TTM)
23.24
Turnover
0.38

EV/EBITDA
58.16

Net Margin
0.00%

Op. Margin
0.00%

ROA
-4.89%

Quick Ratio
0.00

Curr. Ratio
2.30
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Bharat Parenter. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Bharat Parenter. appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Bharat Parenter. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,180.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,43,302.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,623.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma96,836.1025.682.529.25%0.1911.76%394.820.24%0.3841.58

BHARAT PARENTERALS LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹340.38₹261.22₹217.98₹212.01
Other Income₹11.62₹4.68₹11.74₹7.78
Total Revenue₹352.00₹265.90₹229.72₹219.79
Total Expenses₹385.95₹247.17₹206.17₹191.92
Profit Before Tax-₹33.95₹18.72₹23.55₹27.88
Tax₹9.72₹8.21₹7.83₹7.06
Profit After Tax-₹43.68₹10.51₹15.71₹20.81
EPS - Basic-₹66.64₹24.94₹28.40₹36.67
EPS - Diluted-₹66.64₹24.94₹28.40₹36.67

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹33.95₹18.72₹23.55₹27.88
Income before WC changes₹6.54₹34.05₹32.35₹32.73
Change in Assets-₹38.49-₹55.53-₹47.46-₹23.50
Change in Liabilities₹15.30₹26.24₹45.56-₹4.63
Change in WC-₹23.19-₹29.29-₹1.90-₹28.13
Cash flow from Operations-₹27.25-₹4.71₹21.66-₹1.07
Cash flow from Investing-₹137.39-₹104.78-₹77.82-₹6.63
Cash flow from Financing₹156.37₹110.43₹60.60₹9.42
Total Cash Flow-₹8.27₹0.94₹4.44₹1.72
Cash (Start of the year)₹8.71₹7.84₹3.40₹1.68
Cash (End of the year)₹0.44₹8.78₹7.84₹3.40

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹293.01₹242.04₹166.06₹82.32
Current Assets₹355.52₹262.00₹184.28₹143.74
Total Assets₹648.53₹504.04₹350.34₹226.06
Current Liabilities₹219.30₹189.83₹119.80₹41.53
Net Current Asset₹136.21₹72.18₹64.49₹102.20
Non-Current Liabilities₹90.23₹76.04₹12.65₹14.38
Equity Capital₹339.00₹238.17₹217.90₹170.14
Total Equity & Liabilities₹648.53₹504.04₹350.34₹226.06

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹304.13₹257.98₹217.98₹212.01
Other Income₹14.55₹8.04₹18.84₹7.78
Total Revenue₹318.68₹266.02₹236.82₹219.79
Total Expenses₹282.37₹235.22₹204.65₹191.42
Profit Before Tax₹36.32₹30.80₹32.17₹28.37
Tax₹9.86₹8.21₹7.83₹7.06
Profit After Tax₹26.45₹22.59₹24.34₹21.30
EPS - Basic₹40.36₹38.81₹42.14₹37.11
EPS - Diluted₹40.36₹38.81₹42.14₹37.11

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹36.32₹30.80₹32.17₹28.37
Income before WC changes₹43.05₹37.25₹33.06₹33.05
Change in Assets-₹20.69-₹47.52-₹71.27-₹46.05
Change in Liabilities₹6.93₹19.58₹35.43-₹3.41
Change in WC-₹13.76-₹27.94-₹35.84-₹49.46
Cash flow from Operations₹19.22-₹0.16-₹11.56-₹22.08
Cash flow from Investing-₹89.69-₹38.19-₹13.95₹21.76
Cash flow from Financing₹69.25₹33.51₹28.52₹2.24
Total Cash Flow-₹1.21-₹4.84₹3.01₹1.93
Cash (Start of the year)₹1.43₹6.34₹3.33₹1.40
Cash (End of the year)₹0.22₹1.50₹6.34₹3.33

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹283.41₹166.84₹133.51₹74.64
Current Assets₹265.78₹220.31₹174.51₹143.36
Total Assets₹549.19₹387.15₹308.03₹218.00
Current Liabilities₹154.62₹167.00₹108.35₹40.21
Net Current Asset₹111.15₹53.31₹66.16₹103.15
Non-Current Liabilities₹7.74₹6.54₹8.62₹11.64
Equity Capital₹386.83₹213.61₹191.06₹166.15
Total Equity & Liabilities₹549.19₹387.15₹308.03₹218.00
* All values are in INR Crore
Qty
Bid
18
1518.2
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 18
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
0
Neutral
3
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

ATR (14)
136.69
Neutral

STOCH(9,6)
58.87
Neutral

ADX(9)
16.33
Bullish

ROC(12)
16.16
Bullish

WillR(14)
-25
Neutral
Period
Simple value
Exponential vaue

5D
1515.96
1512.21

10D
1472.64
1524.36

20D
1428.65
0

50D
1428.65
0

100D
1428.65
0
Volume trend — traded volume by day
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
BHARAT PARENTERALS LTD. Share Price
BHARAT PARENTERALS LTD.
Pharmaceuticals
Add Stock
Add Another

BHARAT PARENTERALS LTD. Share Price FAQs